Ipratropium Bromide Inhalation

Armstrong Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Apr 16, 2026
Approval ID: 133cc2ed-f018-4295-b84e-b24382299360
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use IPRATROPIUM BROMIDE HFA INHALATION AEROSOL safely and effectively.See full prescribing information for IPRATROPIUM BROMIDE HFA INHALATION AEROSOL. IPRATROPIUM BROMIDE HFA inhalation aerosol, for oral inhalation useInitial U.S. Approval: 2004

Quick Stats

Total Products1

Labelers1

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.